FDA advisers reassert case against approval of Biogen's Alzheimer's drug

FDA advisers reassert case against approval of Biogen's Alzheimer's drug

 

I saw this, and am now more than ever convinced ADU won’t be approved. I reached out to tenured reps here, and they all agreed Biogen gives 2 weeks severance for every year worked. For me, in June that will be 4 weeks severance. Any more than that is almost certainly a pipe dream espoused by those on here. Good luck to all in the job search.

 

I don't want to sound naive, but as others have stated on many other posts, Senior leadership from ADU had stated on a ADU call that is there is no approval, employees that are affected will be "taken care of handsomely." That wouldn't be 2 weeks.

If indeed ends up that way, most employees would only get two weeks. Even the best, top of class employees could never get a job in that short timeframe.

 

Hey Genius-if you know so freaking much how come Biogen Leadership doesn’t put this in writing? You sound like just another big pharma Ass Clown.

 

Stop the conjecture and name
Calling. Speculate all you want but only the FDA knows

 

FDA grew too close to Biogen during Alzheimer's drug development, doctors say -

 

What did you expect them to say, “We are just keeping you around to create an illusion of approval and maintain our market value. We don’t give two shlts about you or your family!”

Biogen is known for being cut throat. I don’t think a massive failure is going to change that.

 

RSD and TBM cut immediately. MSL and AAL will be cut by 1/2-2/3 but some will stay on for Sage market prep. ADRM most likely cut too.

 

Yes. They are just giving busy work right now and keeping up with the Team rah, rah, rah when in reality, they all pretty much know the inevitable really doesn't look good. The collaboration direction they are giving is crazy. Ren - We aren't trying to give you more work! The negative JAMA paper is strong and a big indication these FDA advisors are absolutely not standing down. Other organizations will be coming forward as well in all the reasons Aducanumab should not be approved. Most Alzheimer's Specialists believe this drug should not be approved and have kept many Biogen employees to minimum communications as they see it as an enormous waste of time. Biogen employees are also starting to realize that their initial wish of approval would end up being a miserable experience. Think for one minute about the sheer gigantic enormity. No accounts are prepared at all. The indication would be highly ridiculous and it would be 24 hours/7 days of frustration, stress, getting screamed at by HCP's etc. No fun guaranteed.

 

This isn't about noise. This is JAMA for gosh sakes and it is coming from advisory board members saying NO!

 

“But, but, but senior management says........”

Enjoy 2 weeks severance.

 

As a rep who had a mother suffer from and ultimately die due to Alzheimer’s not long ago, this drug, if it really worked/works, would have been a major help for those living with it. Should the FDA somehow decide to approve it, I’m certain that very few if any MD’s would consider prescribing it with all of the scuttlebutt since the filing. Maybe those reps waiting for the looming decision should just take this as a hint to find another job. Don’t be a fool and think you’re safe